Featured Research

from universities, journals, and other organizations

Stanford Researchers Study Emerging Treatment For Chronic Sinus Infections

Date:
December 27, 2002
Source:
Stanford University Medical Center
Summary:
Conducted over 12 months beginning in November 2000, the study is the first to prospectively evaluate the effectiveness of nebulized antibiotics for the treatment of chronic sinusitis following surgery. Results are published in the December issue of Otolaryngology, Head and Neck Surgery.

STANFORD, Calif. Three years ago, Joanne Clark was so miserable from recurring sinus infections and the antibiotics used to treat them that she felt ready to give up. Despite three surgeries, Clark, a resident of Lodi, Calif., continued getting sinus infections every two to four weeks. The painful headaches and feelings of exhaustion, not to mention the severe nausea from oral antibiotics, forced her to quit her job as a physical education teacher. "I felt horrible," she said. "I had headaches all the time. I had no energy. I didn"t want to live a life like this."

Related Articles


Clark eventually came to Stanford Hospital & Clinics where Winston Vaughan, MD, an otolaryngologist, sinus surgeon and director of the Stanford Sinus Center, suggested she participate in a clinical trial of an innovative new treatment. Instead of taking antibiotics in a pill, Clark could breathe them into her sinuses using a nebulizer - a machine that converts medication from a liquid into an inhalable mist.

Conducted over 12 months beginning in November 2000, the study is the first to prospectively evaluate the effectiveness of nebulized antibiotics for the treatment of chronic sinusitis following surgery. Results are published in the December issue of Otolaryngology, Head and Neck Surgery.

After taking the nebulized antibiotics twice daily for three weeks, Clark experienced significant relief. Her symptoms including headaches, congestion and fatigue subsided more quickly than with antibiotic pills, and she remained infection-free far longer - nearly three months. While she experienced some mild side effects, "it was nothing compared with the pills." Most of the other study participants saw similar benefits from nebulized antibiotics. Of the 42 patients studied - all adults who suffered recurrent sinus infections after surgery - 76 percent reported "significant improvement" in symptoms, confirmed through physical exams and sinus endoscopies.

Significantly, the patients who benefited from the treatment remained free of infection for an average of 17 weeks, compared with six weeks previously. Like Clark, they reported few side effects and improved quality of life.

Based on these results, Vaughan believes nebulized antibiotics represent a promising alternative for patients who continue getting sinus infections even after surgery and who have failed, or cannot tolerate, oral or intravenous antibiotics. "These results are very encouraging," said Vaughan, assistant professor of surgery at the School of Medicine and lead author of the study. Nebulized antibiotics "may serve as a new treatment option in an often frustrating disease process."

Sinusitis affects 35 million Americans, making it the country's most prevalent chronic condition, according to the Centers for Disease Control and Prevention. As Clark"s experience shows, the condition can significantly reduce productivity and quality of life.

"These patients feel miserable," Vaughan said. "They have facial pain, they can't breathe and they can't sleep." Nebulized antibiotics, he said, were developed in the late 1990s "out of a desperate need for something else."

While asthma patients have long relied upon nebulizers to inhale medication into their lungs, the use of nebulized antibiotics to treat sinus infections emerged only in the last two to three years.

Why does the treatment work so well? "The common-sense answer is, we're getting more of the medication directly to the tissues that need it" because the medication is inhaled into the nostrils instead of circulating through the entire body, Vaughan said. He added that more research is needed to understand exactly how the treatment works.

Vaughan chairs the scientific advisory board of SinusPharmacy Corp., a company that formulates nebulized antibiotics and other medications to treat sinus infections. The company"s medications were used in the Stanford study. All data from the study were analyzed independently of the company. The research was funded solely by Stanford University Medical Center.

Clark, for her part, still gets sinus infections three to four times a year, but she said the episodes are far more manageable with nebulized antibiotics. Because her health has improved, she has returned to work at the school district.

"I feel great most of the time," Clark said. "I tell people this treatment gave me my life back."

###

Stanford University Medical Center integrates research, medical education and patient care at its three institutions - Stanford University School of Medicine, Stanford Hospital & Clinics and Lucile Packard Children's Hospital at Stanford. For more information, please visit the Web site of the medical center's Office of Communication & Public Affairs at http://mednews.stanford.edu


Story Source:

The above story is based on materials provided by Stanford University Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

Stanford University Medical Center. "Stanford Researchers Study Emerging Treatment For Chronic Sinus Infections." ScienceDaily. ScienceDaily, 27 December 2002. <www.sciencedaily.com/releases/2002/12/021227070722.htm>.
Stanford University Medical Center. (2002, December 27). Stanford Researchers Study Emerging Treatment For Chronic Sinus Infections. ScienceDaily. Retrieved November 28, 2014 from www.sciencedaily.com/releases/2002/12/021227070722.htm
Stanford University Medical Center. "Stanford Researchers Study Emerging Treatment For Chronic Sinus Infections." ScienceDaily. www.sciencedaily.com/releases/2002/12/021227070722.htm (accessed November 28, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Rural India's Low-Cost Sanitary Pad Revolution

Rural India's Low-Cost Sanitary Pad Revolution

AFP (Nov. 28, 2014) — One man hopes his invention -– a machine that produces cheap sanitary pads –- will help empower Indian women. Duration: 01:51 Video provided by AFP
Powered by NewsLook.com
Research on Bats Could Help Develop Drugs Against Ebola

Research on Bats Could Help Develop Drugs Against Ebola

AFP (Nov. 28, 2014) — In Africa's only biosafety level 4 laboratory, scientists have been carrying out experiments on bats to understand how virus like Ebola are being transmitted, and how some of them resist to it. Duration: 01:18 Video provided by AFP
Powered by NewsLook.com
WHO Says Male Ebola Survivors Should Abstain From Sex

WHO Says Male Ebola Survivors Should Abstain From Sex

Newsy (Nov. 28, 2014) — WHO cites four studies that say Ebola can still be detected in semen up to 82 days after the onset of symptoms. Video provided by Newsy
Powered by NewsLook.com
Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins